Standout Papers

Antitumour activity of MDV3100 in castration-resistant pro... 2000 2026 2008 2017 802
  1. Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1–2 study (2010)
    Howard I. Scher, Tomasz M. Beer et al. The Lancet
  2. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality (2000)
    Charlotte Ling, John L. Humm et al. International Journal of Radiation Oncology*Biology*Physics
  3. Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe (2014)
    Evan H. Phillips, Oula Peñate Medina et al. Science Translational Medicine
  4. Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer (2013)
    Alan L. Ho, Ravinder K. Grewal et al. New England Journal of Medicine
  5. Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials. (2006)
    Lalitha Shankar, John M. Hoffman et al. PubMed
  6. Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer (2007)
    Daniel C. Danila, Glenn Heller et al. Clinical Cancer Research
  7. Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15 (2003)
    Renier J. Brentjens, Jean‐Baptiste Latouche et al. Nature Medicine
  8. Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development (2005)
    Gary J. Kelloff, John M. Hoffman et al. Clinical Cancer Research
  9. Radioimmunotherapy of human tumours (2015)
    Steven M. Larson, Jorge A. Carrasquillo et al. Nature reviews. Cancer

Immediate Impact

5 by Nobel laureates 19 from Science/Nature 174 standout
Sub-graph 1 of 18

Citing Papers

CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
65 intermediate papers

Works of Steven M. Larson being referenced

Five-Year Survival Is Similar in Thyroid Cancer Patients with Distant Metastases Prepared for Radioactive Iodine Therapy with either Thyroid Hormone Withdrawal or Recombinant Human TSH
2011
Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
2009
and 31 more

Author Peers

Author Last Decade Papers Cites
Steven M. Larson 21593 12698 10294 690 42.9k
Wim J.G. Oyen 12539 6045 7098 672 30.0k
Richard L. Wahl 19189 8277 6438 528 33.0k
Jürgen Debus 12251 19292 12013 1.3k 42.3k
Peter L. Choyke 18412 31579 7496 1.1k 62.4k
Peter R. Carroll 6327 30126 7308 870 44.9k
Philippe Lambin 28367 16811 8749 705 44.5k
Mithat Gönen 8277 18942 25916 769 58.9k
Wolfgang Weber 15448 9936 6988 690 31.0k
Uwe Haberkorn 16979 12978 11944 499 30.2k
Robert J. Gillies 26455 11409 8681 492 54.6k

All Works

Loading papers...

Rankless by CCL
2026